Back Bay on Bloomberg Baystate Business: Rare Disease Treatments News, UncategorizedBack Bay Life Science AdvisorsMarch 10, 2019BIO Innovation, Biotech, Drug development, Rare diseases
Back Bay Sponsors DKBIO2019 Danish Science & the City EventsJocelyn MillerFebruary 28, 2019Denmark, Drug development, Europe, Investment, Life Science Events
New White Paper: The Microbiome and Immuno-Oncology Blog, Jonathan Barry Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsFebruary 25, 2019cancer treatment, Drug development, immuno-oncology, microbiome
New White Paper: A Rare-Disease Approach to Seizure Treatment Michelle Hoffmann Posts, Susan Thompson Posts, WhitepapersBack Bay Life Science AdvisorsDecember 18, 2018Biotech, Drug development, Epilepsy, Rare diseases, Seizure
Back Bay in STAT: Antibiotic Breakthroughs News, Peter Bak Posts, Back Bay in the NewsBack Bay Life Science AdvisorsDecember 10, 2018Antibiotics, Anti-microbials, Drug development
